News · 26 weeks380%
2026-04-192026-10-11
Mix2390d
- Insider8(35%)
- SEC Filings6(26%)
- Other5(22%)
- Earnings2(9%)
- Leadership2(9%)
Latest news
25 items- PRPETVIVO ANNOUNCES RELEASE OF TWO REASEARCH ABSTRACTS AND UPCOMING CONFERENCE PRESENTATIONS ON OSTEOARTHRITIS IN RHESUS MACAQUESMINNEAPOLIS, MN, Oct. 15, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV) ("PetVivo" or the "Company"), together with its subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., a biomedical device and therapeutics company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals, today announced the release of two research abstracts evaluating intra-articular administration of a collagen-elastin hydrogel, commercially available as the Company’s Spryng® with OsteoCushion® Technology, in rhesus macaques with naturally occurring osteoarthritis. The findings are scheduled for presentation a
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRMichael Handley Joins PetVivo Holdings, Inc. Board of DirectorsMINNEAPOLIS, MN, US, Sept. 22, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (the "Company"), together with its subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced the appointment of Michael K. Handley to its Board of Directors, effective September 22, 2026. "We are pleased to welcome Michael Handley to PetVivo’s Board of Directors," said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. "Michael brings extensive experience in building life sciences companies, raising ca
- PRJaime Pickett Joins PetVivo Holdings, Inc. Board of DirectorsMINNEAPOLIS, MN, US, Sept. 22, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) (the "Company"), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced the appointment of Jaime K. Pickett, DVM, MBA, to its Board of Directors, effective September 22, 2026. "We are pleased to welcome Dr. Jaime Pickett to PetVivo’s Board of Directors," said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. "Jaime brings a valuable combination of veterinary expertise, executive leadership and experience growing veterinary care organizations. Her understanding of clinical practice, hosp
- INSIDERDirector Rudelius Robert James was granted 3,497 shares, increasing direct ownership by 0.87% to 406,889 units (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- PRPETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX:PETV), and its other subsidiaries, Somatrix Technologies, Inc. and PetVivo AI, Inc., an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals today announced its veterinary conference and exhibition schedule for the remainder of 2026 and through April 2027. The conference schedule is designed to provide PetVivo with continued opportunities to engage directly with veterinarians, specialists, practice owners and other animal health professionals; inc
- INSIDERLarge owner A.L. Sarroff Fund, Llc bought $40,022 worth of shares (58,602 units at $0.68) (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERAmendment: Chief Financial Officer Lowenthal Garry N was granted 31,250 shares (SEC Form 4)4/A - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERAmendment: Chief Executive Officer Lai John was granted 31,250 shares, increasing direct ownership by 1% to 2,413,163 units (SEC Form 4)4/A - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 31,250 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 31,250 shares, increasing direct ownership by 1% to 2,413,163 units (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- PRPETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATIONNew Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal Health MINNEAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV) ("PetVivo" or the "Company"), an emerging biomedical device company focused on the commercialization and development of innovative medical devices and therapeutics, announced today that its subsidiary, Cosmeta Corp., has changed its name to Somatrix Technologies, Inc. ("Somatrix"). The new name reflects the Company's strategic vision for Somatrix as a dedicated human health subsidiary focused on the research and development of innovative biomaterial technologies wi
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- SECSEC Form 10-Q filed by PetVivo Holdings Inc.10-Q - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, reported financial and operational results for the first quarter of its fiscal year ended June 30, 2026. PetVivo will hold a conference call today at 5:00 p.m. Eastern time to discuss the results and provide a business update, followed by a question-and-answer period (see dial-in information below). Fiscal Q1 2027 Operational Highlights Announced the acquisition of PiezoBioMembrane (P
- PRPetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ETMINNEAPOLIS, MN, US, Aug. 07, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)), an emerging biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, August 14, 2026 at 5:00 p.m. Eastern time to discuss results for the fiscal first quarter ended June 30, 2026. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal First Quarter 2027 conference call information is as follows: Date: Friday, August 14, 2026Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time
- SECSEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.SCHEDULE 13G - PetVivo Holdings, Inc. (0001512922) (Subject)
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- PRPETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEMAgreement Resolves All Outstanding Matters and Completes Transition of PrecisePRP® Product Line MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)) working in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc. (collectively "PetVivo" or the "Company"), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for horses and companion animals, today announced that it has entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24, 2026. Under the agreement, the parties have terminated their Exclus
- SECPetVivo Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - PetVivo Holdings, Inc. (0001512922) (Filer)
- INSIDERChief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- INSIDERChief Executive Officer Lai John was granted 75,000 shares (SEC Form 4)4 - PetVivo Holdings, Inc. (0001512922) (Issuer)
- PRPetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary RecordPeer-Reviewed Study Demonstrates Feasibility and Statistically Significant Improvements in Subjective Clinical Outcomes in Dogs with Stifle Osteoarthritis and Suspected Cranial Cruciate Disease Minneapolis, MN, July 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp and PetVivo AI, Inc., a leading provider of medical devices and biomedical therapeutics for equines and companion animals, today announced the publication of a peer-reviewed clinical study evaluating Spryng® with OsteoCushion® Technology in the peer-reviewed journal Veterinary Record. The publication repre
- SECSEC Form 10-K filed by PetVivo Holdings Inc.10-K - PetVivo Holdings, Inc. (0001512922) (Filer)
PETV FAQ
6 questionsWhat does PetVivo Holdings Inc. do?
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.Where does PETV stock trade?
PetVivo Holdings Inc. (PETV) is listed on NASDAQ.What sector and industry is PETV in?
PetVivo Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about PETV?
PetVivo Holdings Inc. has had 1 recent analyst action on file. The most recent action was from ThinkEquity: Buy with a $700.00 price target on 2021-10-12. Recent price targets cluster around $700.00.What companies are similar to PETV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare PETV side-by-side with any of them on Quantisnow.How can I track PETV on Quantisnow?
Quantisnow aggregates PetVivo Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETV to receive live email and push alerts on every new disclosure.